Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04500665

Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Brigham and Women's Hospital · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.

Conditions

Interventions

TypeNameDescription
DRUGColchicineColchicine
DRUGPlaceboPlacebo

Timeline

Start date
2021-11-01
Primary completion
2026-07-31
Completion
2026-11-11
First posted
2020-08-05
Last updated
2025-09-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04500665. Inclusion in this directory is not an endorsement.

Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine (NCT04500665) · Clinical Trials Directory